GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » PB Ratio

Pet Pharm Biotech Co (ROCO:7762) PB Ratio : 4.96 (As of Mar. 14, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-14), Pet Pharm Biotech Co's share price is NT$59.30. Pet Pharm Biotech Co's Book Value per Share for the quarter that ended in Jun. 2024 was NT$11.94. Hence, Pet Pharm Biotech Co's PB Ratio of today is 4.96.

The historical rank and industry rank for Pet Pharm Biotech Co's PB Ratio or its related term are showing as below:

ROCO:7762' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 5.43
Current: 5.1

During the past 2 years, Pet Pharm Biotech Co's highest PB Ratio was 5.43. The lowest was 0.00. And the median was 0.00.

ROCO:7762's PB Ratio is ranked worse than
84.2% of 943 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs ROCO:7762: 5.10

Back to Basics: PB Ratio


Pet Pharm Biotech Co PB Ratio Historical Data

The historical data trend for Pet Pharm Biotech Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co PB Ratio Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23
PB Ratio
- -

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
PB Ratio - - - -

Competitive Comparison of Pet Pharm Biotech Co's PB Ratio

For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pet Pharm Biotech Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pet Pharm Biotech Co's PB Ratio falls into.



Pet Pharm Biotech Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pet Pharm Biotech Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=59.30/11.944
=4.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pet Pharm Biotech Co  (ROCO:7762) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pet Pharm Biotech Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pet Pharm Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines